Chelsea Therapeutics International Ltd. (CHTP) was a big mover last session, as the company saw its shares rise by almost 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 28% in the past one-month time frame.
This biotechnology company has seen two positive revisions over the last 30 days and its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Chelsea Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.
Chelsea Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Some better-ranked stocks in the bio-med industry include Heska Corporation (HSKA), Actelion Ltd. (ALIOF) and Amgen Inc. (AMGN). While Heska Corporation and Actelion hold a Zacks Rank #1 (Strong Buy), Amgen carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CHELSEA THERAPEUTICS INTERNATION (CHTP): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
AMGEN INC (AMGN): Free Stock Analysis Report
Zacks Investment Research